ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 132275 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 132275; 2) Community: the network communities that were significantly associated with the response to NSC 132275; 3) Molecule: the relationships between components within communities and NSC 132275; 4) MDR: the compounds that were significantly associated with the NSC 132275.

NSC Compound Enrichment Correlation
NSC 722854 1,4-di-N-oxide-2-phenylcarbonyl-3-trifluoromethylquinoxaline 0.0105972823829604 0.32818023
NSC 730868 (+)-(2R,3R)-6-{4-[(3-hydroxymethyl)oxiran-2-yl]buta-1,3-diyn yl}-2H-pyran-2-one 0.0105972823829604 0.22159266
NSC 732178 Null 0.0105972823829604 0.37885131
NSC 736811 Null 0.0105972823829604 0.43218841
NSC 740 Methotrexate 0.0105972823829604 0.70045727
NSC 740024 4-(2-Benzylthio-4-chloro-5-methylbenzenesulfonyl)-5,7-dimeth yl-2,4-dihydro-[1,2,4]triazepin-3-ylideneamine 0.0105972823829604 0.21546582
NSC 740476 Null 0.0105972823829604 0.36774412
NSC 87222 ACTINOMYCIN C3 0.0105972823829604 0.56640588
NSC 87868 2-Phenylethyl isothiocyanate 0.0105972823829604 0.36126946
NSC 122060 Ethanesulfonic acid, compd. with N-[[3-[2-chloro-4-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)phenoxy]propyl]carbamoyl]metanilyl fluoride (1:1) (8CI) (MF2) 0.0119221520283057 0.68326113
Total:100  Current:34    [First] [Prev] [Next] [Last]